How Long Is Safe? Setting the Cutoff for Uncomplicated Third Stage Length: A Retrospective Case-Control Study.
Shiri Shinar, Anat Schwartz, Sharon Maslovitz...
https://pubmed.ncbi.nlm.nih.gov/26555024/Actively Recruiting
Led by Holy Family Hospital, Nazareth, Israel · Updated on 2026-08-17
100
Participants Needed
1
Research Sites
4 weeks
Total Duration
This research aims to compare maternal outcomes after manual removal of the placenta performed 15 minutes versus 30 minutes following delivery in women at term who have epidural analgesia during spontaneous vaginal birth. The study evaluates differences in postpartum hemoglobin drop between these two timing strategies to better understand their impact on maternal health. Secondary outcomes assessed include rates of blood transfusion, maternal satisfaction, time to first breastfeeding, length of hospital stay, and infection rates. Participants are randomly assigned to one of two groups one group receives manual removal of the placenta 15 minutes after delivery, and the other group waits 30 minutes before manual removal if the placenta has not been delivered naturally. Both groups undergo active management of the third stage of labor, including oxytocin administration. Manual removal is done under epidural analgesia with prophylactic antibiotics given. Immediate manual removal occurs if active bleeding develops, following standard clinical care. During the study, participants are monitored for changes in hemoglobin levels within 24 hours after delivery as the primary outcome. Additional assessments include blood transfusion rates, postpartum blood loss, infection signs within a week, timing of first breastfeeding, hospital stay duration, and maternal satisfaction over seven days. Hemoglobin levels will also be measured up to six weeks postpartum. The total participation spans from delivery through follow-up assessments up to six weeks, with safety and outcome monitoring throughout.
CONDITIONS
Maternal Outcomes Following Manual Lysis of the Placenta.
M
Mais Abu Nofal, M.D.
R
Raed Salim, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Holy Family Hospital, Nazareth, Israel
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - From delivery until placenta removal
Participants undergo manual removal of the placenta either 15 minutes after delivery or after waiting 30 minutes, based on random assignment. Both groups receive active management of labor's third stage with oxytocin, epidural analgesia, and prophylactic antibiotics. Immediate removal occurs if bleeding develops.
Duration - Up to 6 weeks after delivery
Participants are monitored for hemoglobin levels, blood loss, infection signs, breastfeeding initiation, hospital stay length, and maternal satisfaction up to six weeks postpartum.
Regular assessments during hospital stay and follow-up visits
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Shiri Shinar, Anat Schwartz, Sharon Maslovitz...
https://pubmed.ncbi.nlm.nih.gov/26555024/Oluwarotimi I Akinola, Adetokunbo O Fabamwo, Bolaji Oludara...
https://pubmed.ncbi.nlm.nih.gov/23064176/Ozge Tunçalp, João Paulo Souza, Metin Gülmezoglu...
https://pubmed.ncbi.nlm.nih.gov/24054054/C Deneux-Tharaux, A Macfarlane, C Winter...
https://pubmed.ncbi.nlm.nih.gov/19087083/Andrew D Weeks
https://pubmed.ncbi.nlm.nih.gov/18793876/A Setubal, N Clode, J L Bruno-Paiva...
https://pubmed.ncbi.nlm.nih.gov/10413231/G O Obajimi, A O Roberts, C O Aimakhu...
https://pubmed.ncbi.nlm.nih.gov/25161458/Michel Morales, Gilles Ceysens, Nicole Jastrow...
https://pubmed.ncbi.nlm.nih.gov/15327603/Holy Family Hospital, Nazareth, Israel
Lead Sponsor